In Memoriam

Recently published articles about In Memoriam

JCP
In Memoriam: Terence A. Ketter, MD
In Memoriam

In Memoriam: Terence A. Ketter, MD

August 18, 2025

Eminent bipolar disorder researcher and clinician Terence A. Ketter, MD, is remembered.
,
JCP
In Memoriam: Robert M. A. Hirschfeld, MD
In Memoriam

In Memoriam: Robert M. A. Hirschfeld, MD

March 20, 2023

Robert M. A. Hirschfeld is remembered as a pioneer in the phenomenology and treatment of bipolar disorder.
JCP
In Memoriam: Joseph Biederman, MD
In Memoriam

In Memoriam: Joseph Biederman, MD

February 22, 2023

Colleagues and friends remember Joseph Biederman and reflect on his legacy as the father of pediatric psychopharmacology.
, , , et al
JCP
In Memoriam: Charles Bowden, MD, 1938–2022
In Memoriam

In Memoriam: Charles Bowden, MD, 1938–2022

September 5, 2022

Over his long and distinguished career, Charles Bowden, MD, was a tireless advocate for bipolar disorder patients and an inspiration to colleagues. Trisha Suppes and Gary Sachs reflect on...
,
JCP
In Memoriam: Jan Fawcett, MD
In Memoriam

In Memoriam: Jan Fawcett, MD

July 11, 2022

A. John Rush and Steven D. Hollon reflect on Fawcett’s life and his contributions to the field, especially in the areas of treatment-resistant depression and suicide.
,
JCP
In Memoriam

In Memoriam: Aaron T. Beck, MD

January 4, 2022

Aaron T. Beck, founding father of Cognitive Therapy, was ranked the fourth most influential person in the history of medicine in a 2016 survey. Colleague and friend Michael Thase...

Recent JCP Articles on In Memoriam

PCC
Oral Budesonide-Induced Psychosis
Case Report

Oral Budesonide-Induced Psychosis

October 29, 2026

A 66-year-old woman developed psychosis 1 week after beginning oral budesonide, which resolved with steroid taper
,
PCC
Depression in the Context of Medical Illness
Rounds in the General Hospital

Depression in the Context of Medical Illness

October 29, 2026

For most patients, depression reflects the combined influence of biological vulnerability, symptom burden, functional limitations, and the lived experience of significant medical illness.
, , , et al
Muscarinic Approaches to Schizophrenia, Mechanism, EMERGENT Data, and Open Questions
Webinar

Muscarinic Approaches to Schizophrenia, Mechanism, EMERGENT Data, and Open Questions

October 28, 2026

In this video webinar, Ilan Melnick, MD, discusses muscarinic approaches to schizophrenia, including the proposed M1 and M4 mechanism, short-term and long-term EMERGENT trial findings, and the goal of...

Recent PCC Articles on In Memoriam

Targeted Treatment of Agitation in Alzheimer’s Dementia: Prioritizing Function and Safety Over Sedation and Other Serious Harms
Clinical Pearls

Targeted Treatment of Agitation in Alzheimer’s Dementia: Prioritizing Function and Safety Over Sedation and Other Serious Harms

October 28, 2026

PCC
Managing Propofol Withdrawal
Rounds in the General Hospital

Managing Propofol Withdrawal

October 27, 2026

Propofol withdrawal is an underrecognized but clinically significant syndrome that may occur after prolonged or high-dose infusion in critically ill patients.
, , , et al
PCC
Vascular Mania in Late Life
Case Report

Vascular Mania in Late Life

October 27, 2026

A 61-year-old man developed late-onset mania with psychotic features in the context of acute pontine infarction, autoimmune hyperthyroidism, and atrial fibrillation.
, , , et al

Featured In Memoriam Research

JCP
Bonus Episode: Psychedelic Research Inside an Academic Medical Center with Scott Thompson, PhD
Podcast

Bonus Episode: Psychedelic Research Inside an Academic Medical Center with Scott Thompson, PhD

October 27, 2026

Scott Thompson, PhD, discusses psychedelic research at CU Anschutz, real-world Colorado psilocybin outcomes, 5-HT2A mechanisms, and LSD phase III results.
,
JCP
Lithium and Prevention of Postpartum Mood Disorder Recurrence
Meta-Analysis

Lithium and Prevention of Postpartum Mood Disorder Recurrence

October 26, 2026

Findings from an analysis of 10 studies suggest lithium is effective in preventing postpartum recurrence of mood disorders.
, , , et al
JCP
Electroconvulsive Therapy and Long-Term Risk of Dementia
Clinical and Practical Psychopharmacology

Electroconvulsive Therapy and Long-Term Risk of Dementia

October 26, 2026

Conceptual issues, methodological issues, and findings related to long-term risk of dementia with ECT are discussed.
JCP
In Memoriam

In Memoriam: Frederick K. Goodwin, MD

October 13, 2020

S. Nassir Ghaemi reflects on the life and accomplishments of this founding pioneer of psychopharmacology.
JCP
In Memoriam

Donald F. Klein, MD, DSc: 1928-2019

September 17, 2019

A reflection on the legacy and contributions of Donald F. Klein, a founding member of ASCP and pioneer in the modern era of psychiatry.
,
JCP
In Memoriam

Who Was Lori Altshuler?

March 23, 2016

Read about Lori Altshuler's life and how she effected psychiatry throughout her life.
JCP
In Memoriam

Robert L. Spitzer, MD 1932-2015

February 24, 2016

JCP
In Memoriam

In Memoriam: Andrew C. Leon, PhD, 1951-2012

April 15, 2012

JCP
In Memoriam

In Memoriam: Leon J. Thal, MD, 1944-2007

April 16, 2007

,

Insightful. Evidence-based. Human-centered.

Listen Now
Psychiatrist Steven Berkowitz, MD, discusses psychedelic medicine for trauma treatment

Subscribe to read
more articles

Subscribe